company background image
CHG

Chularat Hospital SET:CHG Stock Report

Last Price

฿3.88

Market Cap

฿42.7b

7D

2.6%

1Y

-3.0%

Updated

13 Aug, 2022

Data

Company Financials +
CHG fundamental analysis
Snowflake Score
Valuation3/6
Future Growth0/6
Past Performance6/6
Financial Health6/6
Dividends3/6

CHG Stock Overview

Chularat Hospital Public Company Limited operates clinics and hospitals in Thailand.

Chularat Hospital Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Chularat Hospital
Historical stock prices
Current Share Price฿3.88
52 Week High฿4.16
52 Week Low฿3.08
Beta0.14
1 Month Change4.87%
3 Month Change3.74%
1 Year Change-3.00%
3 Year Change68.70%
5 Year Change68.70%
Change since IPO345.98%

Recent News & Updates

Shareholder Returns

CHGTH HealthcareTH Market
7D2.6%2.7%1.3%
1Y-3.0%25.1%8.0%

Return vs Industry: CHG underperformed the TH Healthcare industry which returned 25.1% over the past year.

Return vs Market: CHG underperformed the TH Market which returned 8% over the past year.

Price Volatility

Is CHG's price volatile compared to industry and market?
CHG volatility
CHG Average Weekly Movement3.0%
Healthcare Industry Average Movement4.3%
Market Average Movement4.7%
10% most volatile stocks in TH Market10.4%
10% least volatile stocks in TH Market2.3%

Stable Share Price: CHG is less volatile than 75% of TH stocks over the past 3 months, typically moving +/- 3% a week.

Volatility Over Time: CHG's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1986n/aKumpol Plussindhttps://www.chularat.com

Chularat Hospital Public Company Limited operates clinics and hospitals in Thailand. It operates through two segments, Hospital Operations and Other Businesses. The company also distributes medical instruments and dietary supplement products.

Chularat Hospital Fundamentals Summary

How do Chularat Hospital's earnings and revenue compare to its market cap?
CHG fundamental statistics
Market Cap฿42.68b
Earnings (TTM)฿5.31b
Revenue (TTM)฿14.17b

8.0x

P/E Ratio

3.0x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
CHG income statement (TTM)
Revenue฿14.17b
Cost of Revenue฿6.59b
Gross Profit฿7.58b
Other Expenses฿2.27b
Earnings฿5.31b

Last Reported Earnings

Mar 31, 2022

Next Earnings Date

n/a

Earnings per share (EPS)0.48
Gross Margin53.48%
Net Profit Margin37.48%
Debt/Equity Ratio4.1%

How did CHG perform over the long term?

See historical performance and comparison

Dividends

5.2%

Current Dividend Yield

41%

Payout Ratio

Does CHG pay a reliable dividends?

See CHG dividend history and benchmarks
When do you need to buy CHG by to receive an upcoming dividend?
Chularat Hospital dividend dates
Ex Dividend DateAug 24 2022
Dividend Pay DateSep 09 2022
Days until Ex dividend10 days
Days until Dividend pay date26 days

Does CHG pay a reliable dividends?

See CHG dividend history and benchmarks
We’ve recently updated our valuation analysis.

Valuation

Is CHG undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • Analyst Forecast

Key Valuation Metric

Which metric is best to use when looking at relative valuation for CHG?

Other financial metrics that can be useful for relative valuation.

CHG key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue2.8x
Enterprise Value/EBITDA5.6x
PEG Ratio-0.3x

Price to Earnings Ratio vs Peers

How does CHG's PE Ratio compare to its peers?

CHG PE Ratio vs Peers
The above table shows the PE ratio for CHG vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPEEstimated GrowthMarket Cap
Peer Average21.9x
BCH Bangkok Chain Hospital
6x-30.3%฿51.4b
PRINC Principal Capital
27.4x5.1%฿26.1b
RAM Ramkhamhaeng Hospital
15x-23.2%฿68.4b
THG Thonburi Healthcare Group
27.3x-33.6%฿56.8b
CHG-R Chularat Hospital
8x-28.7%฿42.7b

Price-To-Earnings vs Peers: CHG is good value based on its Price-To-Earnings Ratio (8x) compared to the peer average (21.9x).


Price to Earnings Ratio vs Industry

How does CHG's PE Ratio compare vs other companies in the TH Healthcare Industry?

Price-To-Earnings vs Industry: CHG is good value based on its Price-To-Earnings Ratio (8x) compared to the TH Healthcare industry average (14.8x)


Price to Earnings Ratio vs Fair Ratio

What is CHG's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

CHG PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio8x
Fair PE Ratio14.8x

Price-To-Earnings vs Fair Ratio: CHG is good value based on its Price-To-Earnings Ratio (8x) compared to the estimated Fair Price-To-Earnings Ratio (14.8x).


Share Price vs Fair Value

What is the Fair Price of CHG when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: CHG (THB3.88) is trading above our estimate of fair value (THB2.47)

Significantly Below Fair Value: CHG is trading above our estimate of fair value.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Target price is less than 20% higher than the current share price.


Discover undervalued companies

Future Growth

How is Chularat Hospital forecast to perform in the next 1 to 3 years based on estimates from 14 analysts?

Future Growth Score

0/6

Future Growth Score 0/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


-28.7%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: CHG's earnings are forecast to decline over the next 3 years (-28.7% per year).

Earnings vs Market: CHG's earnings are forecast to decline over the next 3 years (-28.7% per year).

High Growth Earnings: CHG's earnings are forecast to decline over the next 3 years.

Revenue vs Market: CHG's revenue is expected to decline over the next 3 years (-11.7% per year).

High Growth Revenue: CHG's revenue is forecast to decline over the next 3 years (-11.7% per year).


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: CHG's Return on Equity is forecast to be low in 3 years time (18.3%).


Discover growth companies

Past Performance

How has Chularat Hospital performed over the past 5 years?

Past Performance Score

6/6

Past Performance Score 6/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


46.6%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: CHG has high quality earnings.

Growing Profit Margin: CHG's current net profit margins (37.5%) are higher than last year (16.8%).


Past Earnings Growth Analysis

Earnings Trend: CHG's earnings have grown significantly by 46.6% per year over the past 5 years.

Accelerating Growth: CHG's earnings growth over the past year (463.6%) exceeds its 5-year average (46.6% per year).

Earnings vs Industry: CHG earnings growth over the past year (463.6%) exceeded the Healthcare industry 231.4%.


Return on Equity

High ROE: CHG's Return on Equity (58.6%) is considered outstanding.


Discover strong past performing companies

Financial Health

How is Chularat Hospital's financial position?

Financial Health Score

6/6

Financial Health Score 6/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Debt Coverage

  • Interest Coverage

Financial Position Analysis

Short Term Liabilities: CHG's short term assets (THB7.6B) exceed its short term liabilities (THB2.6B).

Long Term Liabilities: CHG's short term assets (THB7.6B) exceed its long term liabilities (THB506.8M).


Debt to Equity History and Analysis

Debt Level: CHG has more cash than its total debt.

Reducing Debt: CHG's debt to equity ratio has reduced from 20.1% to 4.1% over the past 5 years.

Debt Coverage: CHG's debt is well covered by operating cash flow (1310.1%).

Interest Coverage: CHG's interest payments on its debt are well covered by EBIT (405.2x coverage).


Balance Sheet


Discover healthy companies

Dividend

What is Chularat Hospital current dividend yield, its reliability and sustainability?

Dividend Score

3/6

Dividend Score 3/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Cash Flow Coverage


5.15%

Current Dividend Yield

Upcoming Dividend Payment

TodayAug 13 2022Ex Dividend DateAug 24 2022Dividend Pay DateSep 09 202216 days from Ex DividendBuy in the next 10 days to receive the upcoming dividend

Dividend Yield vs Market

Notable Dividend: CHG's dividend (5.15%) is higher than the bottom 25% of dividend payers in the TH market (1.69%).

High Dividend: CHG's dividend (5.15%) is low compared to the top 25% of dividend payers in the TH market (5.46%).


Stability and Growth of Payments

Stable Dividend: Whilst dividend payments have been stable, CHG has been paying a dividend for less than 10 years.

Growing Dividend: CHG's dividend payments have increased, but the company has only paid a dividend for 9 years.


Earnings Payout to Shareholders

Earnings Coverage: With its reasonably low payout ratio (41.4%), CHG's dividend payments are well covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: With its reasonably low cash payout ratio (50%), CHG's dividend payments are well covered by cash flows.


Discover strong dividend paying companies

Management

How experienced are the management team and are they aligned to shareholders interests?

9.8yrs

Average management tenure


CEO

Kumpol Plussind (69 yo)

18.58yrs

Tenure

฿340,000

Compensation

Dr. Kumphol Plussind, M.D. has been Chief Executive Officer, Managing Director and Executive Director at Chularat Hospital Public Company Limited since 2004. Dr. Plussind has been a Director of Thai Amdon...


Leadership Team

Experienced Management: CHG's management team is seasoned and experienced (9.8 years average tenure).


Board Members

Experienced Board: CHG's board of directors are seasoned and experienced ( 18.6 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Chularat Hospital Public Company Limited's employee growth, exchange listings and data sources


Key Information

  • Name: Chularat Hospital Public Company Limited
  • Ticker: CHG
  • Exchange: SET
  • Founded: 1986
  • Industry: Health Care Facilities
  • Sector: Healthcare
  • Implied Market Cap: ฿42.680b
  • Shares outstanding: 11.00b
  • Website: https://www.chularat.com

Location

  • Chularat Hospital Public Company Limited
  • 88/8-9, Teparak Km. 15 Road
  • Tambol Bangpla
  • Samut Prakan
  • 10540
  • Thailand

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/08/13 00:00
End of Day Share Price2022/08/11 00:00
Earnings2022/03/31
Annual Earnings2021/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.